相似文献
1
Monoclonal antibodies capable of distinguishing epizootic from enzootic varieties of subtype 1 Venezuelan equine encephalitis viruses in a rapid indirect immunofluorescence assay.
J Clin Microbiol. 1997 Jul;35(7):1887-90. doi: 10.1128/jcm.35.7.1887-1890.1997.
2
Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses.
Vaccine. 1995 Feb;13(3):281-8. doi: 10.1016/0264-410x(95)93315-z.
3
Monoclonal antibodies define antigenic variation in the ID variety of Venezuelan equine encephalitis virus.
Am J Trop Med Hyg. 1988 Jan;38(1):187-94. doi: 10.4269/ajtmh.1988.38.187.
4
Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus.
J Virol. 1997 Sep;71(9):6697-705. doi: 10.1128/JVI.71.9.6697-6705.1997.
5
Association of Venezuelan equine encephalitis virus subtype IE with two equine epizootics in Mexico.
Am J Trop Med Hyg. 1998 Jul;59(1):100-7. doi: 10.4269/ajtmh.1998.59.100.
6
Virulence and viremia characteristics of 1992 epizootic subtype IC Venezuelan equine encephalitis viruses and closely related enzootic subtype ID strains.
Am J Trop Med Hyg. 2001 Jul;65(1):64-9. doi: 10.4269/ajtmh.2001.65.64.
7
Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group.
Lancet. 1996 Aug 17;348(9025):436-40. doi: 10.1016/s0140-6736(96)02275-1.
8
A novel, rapid assay for detection and differentiation of serotype-specific antibodies to Venezuelan equine encephalitis complex alphaviruses.
Am J Trop Med Hyg. 2005 Jun;72(6):805-10.
9
Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus.
J Virol. 2002 Feb;76(4):1718-30. doi: 10.1128/jvi.76.4.1718-1730.2002.
10
Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru.
Am J Trop Med Hyg. 1997 Jun;56(6):661-7. doi: 10.4269/ajtmh.1997.56.661.
引用本文的文献
1
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress.
Cell. 2021 Aug 19;184(17):4430-4446.e22. doi: 10.1016/j.cell.2021.07.033.
2
Seroepidemiology of selected alphaviruses and flaviviruses in bats in Trinidad.
Zoonoses Public Health. 2015 Feb;62(1):53-60. doi: 10.1111/zph.12118. Epub 2014 Apr 17.
3
Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.
J Virol. 2014 Feb;88(3):1771-80. doi: 10.1128/JVI.02297-13. Epub 2013 Nov 20.
4
Production of IL-8, IL-17, IFN-gamma and IP-10 in human astrocytes correlates with alphavirus attenuation.
Vet Microbiol. 2013 May 3;163(3-4):223-34. doi: 10.1016/j.vetmic.2012.11.021. Epub 2013 Jan 11.
5
Venezuelan equine encephalitis virus activity in the Gulf Coast region of Mexico, 2003-2010.
PLoS Negl Trop Dis. 2012;6(11):e1875. doi: 10.1371/journal.pntd.0001875. Epub 2012 Nov 1.
6
Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo.
PLoS One. 2012;7(5):e37242. doi: 10.1371/journal.pone.0037242. Epub 2012 May 30.
7
Alphaviruses: population genetics and determinants of emergence.
Antiviral Res. 2012 Jun;94(3):242-57. doi: 10.1016/j.antiviral.2012.04.002. Epub 2012 Apr 19.
8
Development of human-murine chimeric immunoglobulin G for use in the serological detection of human flavivirus and alphavirus antibodies.
Clin Vaccine Immunol. 2010 Oct;17(10):1617-23. doi: 10.1128/CVI.00097-10. Epub 2010 Aug 25.
9
The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.
PLoS Negl Trop Dis. 2010 Jul 13;4(7):e739. doi: 10.1371/journal.pntd.0000739.
10
CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus.
Vaccine. 2009 Jun 19;27(30):4064-73. doi: 10.1016/j.vaccine.2009.04.015. Epub 2009 May 3.
本文引用的文献
1
Molecular evidence that epizootic Venezuelan equine encephalitis (VEE) I-AB viruses are not evolutionary derivatives of enzootic VEE subtype I-E or II viruses.
J Gen Virol. 1993 Mar;74 ( Pt 3):519-23. doi: 10.1099/0022-1317-74-3-519.
2
Emergence of a new epidemic/epizootic Venezuelan equine encephalitis virus in South America.
Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5278-81. doi: 10.1073/pnas.92.12.5278.
3
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.
J Virol. 1993 Mar;67(3):1269-77. doi: 10.1128/JVI.67.3.1269-1277.1993.
4
Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies.
Virology. 1983 Jul 15;128(1):118-26. doi: 10.1016/0042-6822(83)90323-9.
5
Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies.
Virology. 1982 Apr 30;118(2):269-78. doi: 10.1016/0042-6822(82)90346-4.
6
Monoclonal antibodies define antigenic variation in the ID variety of Venezuelan equine encephalitis virus.
Am J Trop Med Hyg. 1988 Jan;38(1):187-94. doi: 10.4269/ajtmh.1988.38.187.
7
The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes.
Virology. 1985 Apr 30;142(2):347-56. doi: 10.1016/0042-6822(85)90343-5.
8
Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus.
Virology. 1985 Apr 30;142(2):334-46. doi: 10.1016/0042-6822(85)90342-3.
9
Identification of monoclonal antibodies capable of differentiating antigenic varieties of eastern equine encephalitis viruses.
Am J Trop Med Hyg. 1990 Apr;42(4):394-8. doi: 10.4269/ajtmh.1990.42.394.
10
Use of a new synthetic-peptide-derived monoclonal antibody to differentiate between vaccine and wild-type Venezuelan equine encephalomyelitis viruses.
J Clin Microbiol. 1991 Mar;29(3):630-1. doi: 10.1128/jcm.29.3.630-631.1991.
Zotero 插件